Treatment and Follow-Up Recommendations in Acute Respiratory Distress Syndrome Due to COVID-19 Infection


Creative Commons License

AYDOĞDU M.

JOURNAL OF CRITICAL & INTENSIVE CARE, vol.11, pp.12-13, 2020 (ESCI) identifier identifier

  • Publication Type: Article / Review
  • Volume: 11
  • Publication Date: 2020
  • Doi Number: 10.37678/dcybd.2020.2381
  • Journal Name: JOURNAL OF CRITICAL & INTENSIVE CARE
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.12-13
  • Keywords: COVID-19, Respiratory Failure, ARDS, Hypoxia, Mechanical Ventilation
  • Gazi University Affiliated: Yes

Abstract

The actual incidence of hypoxic respiratory failure in the novel coronavirus disease 2019 (COVID-19) patients is not yet clear. It was reported that approximately 14% of COVID-19 patients have severe disease requiring oxygen treatment, 5% need intensive care unit (ICU) admission and mechanical ventilation (MV). In these patients acute respiratory distress syndrome (ARDS) is the main problem that requires careful and comprehensive strategies of treatment in order to prevent mortality. In this short review, guidelines about COVID-19 treatment were evaluated and a summary of recommendations and their explanations were made for the treatment and follow-up of ARDS due to COVID-19 infection.